BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

526445

INDRANIB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

INDRAYANI BIOTECH LTD. Share Price Update

As of the latest trading session, INDRAYANI BIOTECH LTD. share price is currently at ₹ 12.45, which is up by ₹ 0.15 from its previous closing. Today, the stock has fluctuated between ₹ 12.45 and ₹ 12.45. Over the past year, INDRAYANI BIOTECH LTD. has achieved a return of -73.54 %. In the last month alone, the return has been -3.45 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

INDRAYANI BIOTECH LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    56.00

  • P/E Ratio (TTM)

    102.42

  • Beta

    0.35

  • Book Value / share

    12.15

  • Return on equity

    2.78%

  • EPS (TTM)

    0.12

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.13

info icon alternate text

INDRAYANI BIOTECH LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 6.69
Operating Expense 7.40
Net Profit 0.13
Net Profit Margin (%) 1.94
Earnings Per Share (EPS) 0.03
EBITDA 1.40
Effective Tax Rate (%) 23.52
Particulars MAR 2025 (Values in Cr)
Revenue 9.28
Operating Expense 11.47
Net Profit 0.20
Net Profit Margin (%) 2.15
Earnings Per Share (EPS) 0.25
EBITDA 1.72
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 8.19
Operating Expense 8.70
Net Profit 0.11
Net Profit Margin (%) 1.34
Earnings Per Share (EPS) 0.02
EBITDA 1.98
Effective Tax Rate (%) 28.57
Particulars SEP 2024 (Values in Cr)
Revenue 9.51
Operating Expense 10.27
Net Profit 0.10
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.02
EBITDA 2.34
Effective Tax Rate (%) 23.07
Particulars JUN 2024 (Values in Cr)
Revenue 10.79
Operating Expense 11.65
Net Profit 0.13
Net Profit Margin (%) 1.20
Earnings Per Share (EPS) 0.03
EBITDA 1.42
Effective Tax Rate (%) 23.52
Particulars MAR 2025 (Values in Cr)
Revenue 37.77
Operating Expense 40.63
Net Profit 1.45
Net Profit Margin (%) 3.83
Earnings Per Share (EPS) 0.32
EBITDA 5.93
Effective Tax Rate (%) -123.07
Particulars MAR 2024 (Values in Cr)
Revenue 62.32
Operating Expense 62.94
Net Profit 1.46
Net Profit Margin (%) 2.34
Earnings Per Share (EPS) 0.32
EBITDA 9.29
Effective Tax Rate (%) 51.49
Particulars MAR 2023 (Values in Cr)
Revenue 74.48
Operating Expense 69.54
Net Profit 5.06
Net Profit Margin (%) 6.79
Earnings Per Share (EPS) 1.48
EBITDA 8.79
Effective Tax Rate (%) 0.39
Particulars MAR 2022 (Values in Cr)
Revenue 57.99
Operating Expense 53.98
Net Profit 4.23
Net Profit Margin (%) 7.29
Earnings Per Share (EPS) 1.23
EBITDA 6.45
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 21.01
Operating Expense 28.05
Net Profit -10.89
Net Profit Margin (%) -51.83
Earnings Per Share (EPS) -3.18
EBITDA -8.53
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.86
ROE % 18.22
ROCE % 13.76
Total Debt to Total Equity 1.49
EBITDA Margin 14.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.94
ROE % 29.31
ROCE % 19.98
Total Debt to Total Equity 1.12
EBITDA Margin 13.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 16.46
ROCE % 14.34
Total Debt to Total Equity 0.78
EBITDA Margin 11.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.76
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.58
EBITDA Margin -22.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.70
ROE % 2.37
ROCE % 4.09
Total Debt to Total Equity 0.45
EBITDA Margin 5.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.07
ROE % 2.78
ROCE % 7.23
Total Debt to Total Equity 1.00
EBITDA Margin 15.12
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.79
ROE % 12.48
ROCE % 10.59
Total Debt to Total Equity 0.79
EBITDA Margin 11.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 15.61
ROCE % 14.18
Total Debt to Total Equity 0.73
EBITDA Margin 11.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.57
EBITDA Margin -20.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.70
ROE % 4.83
ROCE % 8.18
Total Debt to Total Equity 0.48
EBITDA Margin 5.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.58
Total Assets 235.02
Total Liabilities 235.02
Total Equity 76.26
Share Outstanding 45536256
Price to Book Ratio 4.44
Return on Assets (%) 2.70
Return on Capital (%) 3.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 155.96
Total Liabilities 155.96
Total Equity 48.35
Share Outstanding 34227192
Price to Book Ratio 4.79
Return on Assets (%) 5.60
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 51.40
Total Liabilities 51.40
Total Equity 24.56
Share Outstanding 34227192
Price to Book Ratio 4.32
Return on Assets (%) 8.63
Return on Capital (%) 10.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.67
Total Assets 40.05
Total Liabilities 40.05
Total Equity 20.08
Share Outstanding 34227192
Price to Book Ratio 1.09
Return on Assets (%) -27.99
Return on Capital (%) -31.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 51.47
Total Liabilities 51.47
Total Equity 30.83
Share Outstanding 3643860
Price to Book Ratio 11.93
Return on Assets (%) 1.56
Return on Capital (%) 1.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 126.00
Total Liabilities 126.00
Total Equity 54.51
Share Outstanding 45536256
Price to Book Ratio 4.44
Return on Assets (%) 1.15
Return on Capital (%) 1.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 100.29
Total Liabilities 100.29
Total Equity 51.14
Share Outstanding 34227192
Price to Book Ratio 4.79
Return on Assets (%) 5.04
Return on Capital (%) 5.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.44
Total Assets 49.43
Total Liabilities 49.43
Total Equity 24.17
Share Outstanding 34227192
Price to Book Ratio 4.32
Return on Assets (%) 8.54
Return on Capital (%) 10.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.62
Total Assets 39.84
Total Liabilities 39.84
Total Equity 19.95
Share Outstanding 34227192
Price to Book Ratio 1.09
Return on Assets (%) -27.32
Return on Capital (%) -30.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 51.47
Total Liabilities 51.47
Total Equity 30.83
Share Outstanding 3643860
Price to Book Ratio 11.93
Return on Assets (%) 1.56
Return on Capital (%) 1.81
Particulars MAR 2024 (Values in Cr)
Net Income 10.42
Cash from Operations -30.35
Cash from Investing -16.33
Cash from Financing 44.23
Net change in Cash -2.45
Free Cash Flow -13.86
Particulars MAR 2023 (Values in Cr)
Net Income 11.93
Cash from Operations 16.18
Cash from Investing -47.39
Cash from Financing 32.73
Net change in Cash 1.53
Free Cash Flow 37.71
Particulars MAR 2022 (Values in Cr)
Net Income 4.43
Cash from Operations 4.11
Cash from Investing -0.55
Cash from Financing -2.72
Net change in Cash 0.82
Free Cash Flow 5.30
Particulars MAR 2021 (Values in Cr)
Net Income -11.21
Cash from Operations 0.25
Cash from Investing -0.70
Cash from Financing -0.27
Net change in Cash -0.72
Free Cash Flow 0.95
Particulars MAR 2020 (Values in Cr)
Net Income 0.80
Cash from Operations 5.95
Cash from Investing -3.66
Cash from Financing -1.28
Net change in Cash 1.01
Free Cash Flow 9.44
Particulars MAR 2024 (Values in Cr)
Net Income 3.00
Cash from Operations 26.08
Cash from Investing -7.25
Cash from Financing -19.18
Net change in Cash -0.35
Free Cash Flow 32.43
Particulars MAR 2023 (Values in Cr)
Net Income 5.05
Cash from Operations 8.33
Cash from Investing -14.09
Cash from Financing 4.93
Net change in Cash -0.82
Free Cash Flow 10.23
Particulars MAR 2022 (Values in Cr)
Net Income 4.22
Cash from Operations 3.46
Cash from Investing 0.58
Cash from Financing -3.23
Net change in Cash 0.81
Free Cash Flow 3.52
Particulars MAR 2021 (Values in Cr)
Net Income -10.88
Cash from Operations 0.51
Cash from Investing -0.56
Cash from Financing -0.73
Net change in Cash -0.77
Free Cash Flow 0.90
Particulars MAR 2020 (Values in Cr)
Net Income 0.80
Cash from Operations 5.95
Cash from Investing -3.66
Cash from Financing -1.28
Net change in Cash 1.01
Free Cash Flow 9.44
Company Name Price P/E P/B Market Cap 52 Week Low/High
MAFATLAL INDUSTRIES LTD. 142.55 8.60 1.38 1026.77 111.50 / 210.00
MAJESTIC AUTO LTD. 346.30 36.57 0.58 360.15 271.00 / 467.70
ANDREW YULE & COMPANY LTD. 26.50 64.63 3.82 1295.72 22.65 / 50.00
BALMER LAWRIE & CO LTD 231.05 14.58 2.00 3951.04 146.70 / 292.10
Company Name Price P/E P/B Market Cap 52 Week Low/High
MAFATLAL INDUSTRIES LTD. 142.55 8.58 1.38 1026.77 111.50 / 210.00
EMPIRE INDUSTRIES LTD. 1169.20 20.40 2.23 701.52 922.00 / 1599.00
MAJESTIC AUTO LTD. 346.30 0.00 0.62 360.15 271.00 / 467.70
ANDREW YULE & COMPANY LTD. 26.50 126.19 12.79 1295.72 22.65 / 50.00

INDRAYANI BIOTECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
12.29 1.31 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 12.20
  • 26 Days 12.60
  • 10 Days 12.10
  • 50 Days 13.40
  • 12 Days 12.20
  • 100 Days 15.70
  • 20 Days 12.40
  • 200 Days 21.80
12.28 PIVOT

First Support

11.67

First Resistance

12.75

Second Support

11.20

Second Resistance

13.36

Third Support

10.59

Third Resistance

13.83

RSI

44.97

ADX

12.63

MACD

-0.42

Williams % R

-31.48

Commodity Channel Index (CCI)

-28.24

Date

2025-09-12

Week

85105.00

Same Day

133830.00

Month

61135.00

1 Year

0.35

3 Year

0.35

Over 1 Month

-3.45%

down

Over 1 Year

-73.54%

down

Over 3 Months

-18.33%

down

Over 3 Years

-49.53%

down

Over 6 Months

-36.58%

down

Over 5 Years

6.90%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

INDRAYANI BIOTECH LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
63.61%
Promoter Holdings
33.28%
FII
0.0%
DII
3.1%
Promoter Shares(Pledge Percentage)
24.61%
Name Shares Category
Jayaseelan Singaravelu 4607777.0 (10.12%) Public Shareholding
G Swaminathan 4140000.0 (9.09%) Shareholding of Promoter and Promoter Group
Sayee Sundar Kasiraman 2631569.0 (5.78%) Shareholding of Promoter and Promoter Group
S Indirakumar 2098600.0 (4.61%) Shareholding of Promoter and Promoter Group
I Umasundari 2098600.0 (4.61%) Shareholding of Promoter and Promoter Group
Ajitkumar C Patel 1300000.0 (2.85%) Public Shareholding
Dheeraj Kumar Lohia 1091854.0 (2.4%) Public Shareholding
Malarvannan Subashini 1059064.0 (2.33%) Public Shareholding
M Ramesh 1050000.0 (2.31%) Shareholding of Promoter and Promoter Group
Jothi Ramesh 1050000.0 (2.31%) Shareholding of Promoter and Promoter Group
Lrsd Securities Pvt Ltd 924628.0 (2.03%) Public Shareholding
S Prakash 777500.0 (1.71%) Public Shareholding
Thirumeni Thiruselvaraja 777340.0 (1.71%) Shareholding of Promoter and Promoter Group
S I Dinesh Kumar 700000.0 (1.54%) Shareholding of Promoter and Promoter Group
V Agathiyan 605840.0 (1.33%) Shareholding of Promoter and Promoter Group
Karuppannan A 581980.0 (1.28%) Public Shareholding
Sonal Lohia 534272.0 (1.17%) Public Shareholding
Rajasthan Global Securities Private Limited 491154.0 (1.08%) Public Shareholding
Ramya M 1400.0 (0.0%) Shareholding of Promoter and Promoter Group
K Logan 1400.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

INDRAYANI BIOTECH LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

INDRAYANI BIOTECH LTD. Share Price

Indrayani Biotech Limited was incorporated in 1992. The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus

Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture. The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California.

IBL started exporting flowers to Holland and Dubai during 1994-95. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals.

In 1995-96, the company incurred losses due to reasons beyond the control of the management like insufficient water supply, labour problem and sub-standard infrastructure. To overcome the above problems, the company is considering to shift its green houses to alternate locations.

During the year 2010-11, the Scheme of Arrangement, seeking to reduce the equity share capital of the Company by 88%, conversion of unsecured loan into the equity shares, demerging the entire business into Indrayani Tissue Culture Pvt. Ltd., merging YoGoYo Division of Websource Technologies Ltd., was effective from August 21, 2010. Similarly, the Scheme of Arrangement for Amalgamation of Helios Solutions Limited and A-Diet Express Hospitality Services Limited as a going concern with the Company was made effective from April 1, 2018.

IBL Investments Ltd was incorporated as wholly owned subsidiary company in 2022-23; Dindigul Farm Product Pvt Ltd became subsidiary in 2022-23.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Indrayani Biotech Ltd?

Answer Field

Indrayani Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 12.29 as on Sep 15 2025 09:07 AM.

What is the Market Cap of Indrayani Biotech Ltd Share?

Answer Field

The market cap of Indrayani Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 56.00 as on Sep 15 2025 09:07 AM.

What is the 52 Week High and Low of Indrayani Biotech Ltd?

Answer Field

The 52 Week High and Low of Indrayani Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 48.90 and ₹ 10.20.

What is 1 year return for Indrayani Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -73.54%.

What is the P/E Ratio of Indrayani Biotech Ltd Share?

Answer Field

As on Sep 15 2025 09:07 AM the price-to-earnings (PE) ratio for Indrayani Biotech Ltd share is 102.42.

What is the PB ratio of Indrayani Biotech Ltd Share?

Answer Field

As on Sep 15 2025 09:07 AM, the price-to-book (PB) ratio for Indrayani Biotech Ltd share is 12.15.

How to Buy Indrayani Biotech Ltd Share?

Answer Field

You can trade in Indrayani Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indrayani Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Indrayani Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indrayani Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91